Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
DRNA > SEC Filings for DRNA > Form 8-K on 7-Aug-2014All Recent SEC Filings

Show all filings for DICERNA PHARMACEUTICALS INC

Form 8-K for DICERNA PHARMACEUTICALS INC


7-Aug-2014

Results of Operations and Financial Condition, Financial Statements a


Item 2.02 Results of Operations and Financial Condition.

On August 7, 2014, Dicerna Pharmaceuticals, Inc., a Delaware corporation (the "Company"), issued a press release announcing its financial and operational results for the quarter ended June 30, 2014. A copy of the press release is furnished herewith as Exhibit 99.1.

On July 25, 2014, the Company announced that it would hold a conference call and live audio webcast at 4:30 p.m., eastern time, August 7, 2014, to discuss its financial results and provide a general business update.

The information in this Item 2.02 is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall such information be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise stated in such filing.



Item 9.01 Financial Statements and Exhibits.

Exhibit
  No.                                     Description

99.1         Press Release titled "Dicerna Provides Operational Update and Reports
             Second Quarter 2014 Financial Results" issued by Dicerna
             Pharmaceuticals, Inc. on August 7, 2014.


  Add DRNA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for DRNA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.